Clark Estates Inc’s Medtronic MDT Stock Holding History

Clark Estates Inc’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.4M	Hold	155,000	–	–	3.23%	10
2025 Q4	$14.9M	Sell	155,000 -70,000	-31%	-$6.8M	3.61%	6
2025 Q3	$21.4M	Sell	225,000 -25,000	-10%	-$2.3M	4.9%	3
2025 Q2	$21.8M	Hold	250,000	–	–	4.89%	4
2025 Q1	$22.5M	Hold	250,000	–	–	4.76%	5
2024 Q4	$20M	Sell	250,000 -25,000	-9%	-$2.16M	3.86%	4
2024 Q3	$24.8M	Hold	275,000	–	–	4.61%	3
2024 Q2	$21.6M	Buy	275,000 +20,000	+8%	+$1.64M	4.06%	5
2024 Q1	$22.2M	Sell	255,000 -30,000	-11%	-$2.56M	3.66%	6
2023 Q4	$23.5M	Buy	285,000 +10,000	+4%	+$762K	3.98%	5
2023 Q3	$21.5M	Hold	275,000	–	–	3.92%	7
2023 Q2	$24.2M	Hold	275,000	–	–	4.08%	5
2023 Q1	$22.2M	Hold	275,000	–	–	4.4%	6
2022 Q4	$21.4M	Buy	275,000 +10,000	+4%	+$810K	4.44%	5
2022 Q3	$21.4M	Buy	265,000 +15,000	+6%	+$1.35M	4.73%	3
2022 Q2	$22.4M	Buy	250,000 +200,000	+400%	+$20.3M	3.88%	6
2022 Q1	$5.55M	Buy	+50,000	New	+$5.28M	0.88%	25
2020 Q3	–	Sell	-15,000	Closed	-$1.38M	–	104
2020 Q2	$1.38M	Sell	15,000 -35,000	-70%	-$3.36M	0.24%	91
2020 Q1	$4.51M	Buy	50,000 +26,350	+111%	+$2.8M	0.92%	24
2019 Q4	$2.68M	Hold	23,650	–	–	0.41%	78
2019 Q3	$2.57M	Hold	23,650	–	–	0.42%	75
2019 Q2	$2.3M	Hold	23,650	–	–	0.37%	81
2019 Q1	$2.15M	Hold	23,650	–	–	0.33%	83
2018 Q4	$2.15M	Hold	23,650	–	–	0.34%	83
2018 Q3	$2.33M	Hold	23,650	–	–	0.35%	86
2018 Q2	$2.02M	Sell	23,650 -140,000	-86%	-$11.7M	0.3%	85
2018 Q1	$13.1M	Sell	163,650 -170,972	-51%	-$14.1M	2.1%	15
2017 Q4	$27M	Hold	334,622	–	–	4.46%	4
2017 Q3	$26M	Sell	334,622 -30	-0%	-$2.49K	4.32%	5
2017 Q2	$29.7M	Sell	334,652 -120,000	-26%	-$10.1M	5.1%	4
2017 Q1	$36.6M	Hold	454,652	–	–	5.64%	4
2016 Q4	$32.4M	Buy	454,652 +248,000	+120%	+$19.5M	5.45%	4
2016 Q3	$17.9M	Sell	206,652 -75,575	-27%	-$6.59M	3.45%	8
2016 Q2	$24.5M	Sell	282,227 -142,000	-33%	-$11.5M	4.85%	4
2016 Q1	$31.8M	Sell	424,227 -30,000	-7%	-$2.26M	6.09%	3
2015 Q4	$34.9M	Sell	454,227 -115,754	-20%	-$8.71M	6.31%	3
2015 Q3	$38.2M	Buy	569,981 +113,455	+25%	+$8.36M	6.56%	3
2015 Q2	$33.8M	Sell	456,526 -40,000	-8%	-$3.06M	5.46%	3
2015 Q1	$38.7M	Buy	496,526 +36,616	+8%	+$2.78M	6.26%	4
2014 Q4	$33.2M	Buy	459,910 +79,910	+21%	+$5.55M	4.97%	6
2014 Q3	$23.5M	Buy	380,000 +235,000	+162%	+$14.9M	3.75%	7
2014 Q2	$9.24M	Buy	+145,000	New	+$8.81M	1.32%	19

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clark Estates Inc's MDT Position: Q1 2026 in Review

Clark Estates Inc held its Medtronic (MDT) position steady in Q1 2026 at 155,000 shares worth $13.4M. The position accounts for 3.23% of the portfolio, ranked #10.

Clark Estates Inc first reported a position in MDT in Q2 2014 and has held it in 42 quarters since. The position peaked at $38.7M in Q1 2015. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Clark Estates Inc held 155,000 shares of Medtronic worth $13.4M as of Q1 2026.
Clark Estates Inc left its Medtronic share count unchanged in Q1 2026.
Medtronic made up 3.23% of Clark Estates Inc's portfolio in Q1 2026, its #10 holding.
Clark Estates Inc first reported a position in Medtronic in Q2 2014 and has held it in 42 quarters since.
Clark Estates Inc's Medtronic position peaked at $38.7M in Q1 2015.
2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Clark Estates Inc's 13F filing for Q1 2026, filed 11 May 2026.